Charles River Laboratories International, Inc. (RV6)
XSTU
Closed
Oct 7, 2026
Day's Range
265.7052 wk Range
127.20Overview - RV6 - Charles River Laboratories International, Inc.
Key Statistics
Valuation
P/E (Trailing)
‪-87.93‬
PEG Ratio
‪0.85‬
Price / Book
‪4.25‬
Profitability
Gross Margin
‪36.18%‬
Profit Margin
‪32.95%‬
Operating Margin
‪0.18%‬
Return on Assets
‪-2.02%‬
Return on Equity
‪-4.49%‬
Ownership
Shares Outstanding
47.72M
Price stats
50-Day Avg
‪230.34‬
200-Day Avg
‪177.65‬
Peers - RV6 - Charles River Laboratories International, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- RV6XSTUCharles River Laboratories International, Inc.+51.37%52-week change-87.94P/E (Trailing)‪32.95%‬Profit Margin
- NL0XSTUGRAIL, Inc.+55.16%52-week change-9.98P/E (Trailing)‪-236.94%‬Profit Margin
- 1K9XSTUCareDx Inc.+77.34%52-week change-138.75P/E (Trailing)‪67.55%‬Profit Margin
- 0MEXSTUTwist Bioscience Corporation+85.77%52-week change-123.50P/E (Trailing)‪50.72%‬Profit Margin
- ILUXSTUIllumina Inc.+67.25%52-week change43.70P/E (Trailing)‪66.08%‬Profit Margin
- NG9XSTUNeoGenomics, Inc.+60.85%52-week change-20.33P/E (Trailing)‪43.21%‬Profit Margin
- WX8XSTUWuXi AppTec Co., Ltd.+48.80%52-week change3.50P/E (Trailing)‪47.63%‬Profit Margin
Profile Summary - RV6 - Charles River Laboratories International, Inc.
About
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages. Charles River Laboratories provides research models, discovery services, non-clinical safety assessment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
